Steroid Reduces the Risk for Major Adverse Kidney Events in IgA Nephropathy
A reduced-dose steroid regimen in high-risk IgaN may offer the best balance of risks vs benefits, an investigator stated.
A reduced-dose steroid regimen in high-risk IgaN may offer the best balance of risks vs benefits, an investigator stated.
In a study of patients with stage 4 chronic kidney disease and poorly controlled blood pressure, chlorthalidone significantly decreased systolic blood pressure compared with placebo.
In 2020, nearly 72% of patients in a US study initiated dialysis at an eGFR of 10 mL/min/1.73 m2 or higher.
Lower baseline kidney function and proton pump inhibitor use increased the risk for acute kidney injury associated with immune checkpoint inhibitor therapy.
Metabolic acidosis was defined as serum bicarbonate values of 12 or higher but less than 22 mEq/L.
Receipt of any RBC transfusion was significantly associated with increased risk for venous thromboembolism.
Multimorbidity is more common in patients with chronic kidney disease (CKD) than any other long-term condition, according to investigators.
SGLT2 inhibitors are associated with an initial dip in eGFR, so nephrologists need to monitor kidney function.
Elevated parathyroid hormone has been reported as a potential risk factor for cognitive impairment.
Patients who survive the first 30 days of COVID-19 are more likely to have acute kidney injury and chronic kidney disease compared with those who do not contract the disease.